Over a month ago |
Hot Stocks
|
Planet Labs successfully… Planet Labs successfully launched 36 SuperDove satellites, its Flock 4y, to space aboard a SpaceX Falcon 9 rocket. The Planet team has established contact with all 36 SuperDoves and has kicked off their automated commissioning process. This marks the company's 32nd successful launch, totaling over 500 satellites launched since its founding. These satellites were lofted into orbit from Space Launch Complex 40 in Cape Canaveral, Florida on SpaceX's Transporter-6 mission, marking Planet's eighth flight with the launch provider. Once in orbit, contact with the 36 SuperDoves was established, holding the company's 100% successful contact rate with its satellites. These 36 SuperDoves will replenish Planet's current fleet of approximately 200 satellites in orbit, working to scan the Earth every day to make change visible, accessible, and actionable. This data is incorporated into the workflows of over 800 customers globally and thousands of users in agriculture, sustainability, government, and more, to help power better decision making. From measuring crop yields to fighting illegal deforestation to supporting land restoration efforts, global users are finding great value in Planet's monitoring capabilities. The company is excited to bring even more SuperDove satellites to orbit to further its mission of making daily change visible, accessible, and actionable. ShowHide Related Items >><< - 12/16/22
- Planet Labs rises 10.2%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/19/22 Northland
- Maxar deal sheds light on growing value of Planet Labs data, says Northland
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- Sell these stocks now, proven algorithm says
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/14/22
- Planet Labs PBC options imply 9.7% move in share price post-earnings
- 09/12/22
- Planet Labs PBC options imply 9.2% move in share price post-earnings
|
Recommendations
|
After Maxar Technologies… After Maxar Technologies (MAXR) announced last week that it agreed to an acquisition by defense and security-focused PE firm Advent International for a 129% premium, Northland analyst Michael Latimore acknowledged that Maxar has a different business model than Planet Labs' (PL), but he also argued that the acquisition "sheds more light on the growing value of geospatial data." The analyst, who believes Planet is "focused on growing into the earth image data subscription category leader" and contends that potential acquirers would include tech companies like Google (GOOGL), keeps an Outperform rating and $12 price target on Planet Labs shares. ShowHide Related Items >><< - 12/16/22
- Planet Labs rises 10.2%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- $51.85 /
+28.8 (+124.95%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/18/22
- Fly Intel: Top five weekend stock stories
- 12/12/22
- UnitedHealth appoints Kristen Gil to board of directors
- 12/12/22
- UnitedHealth appoints Alphabet business finance officer Kristen Gil to board
- 12/07/22
- Alphabet, Oracle, Amazon and Microsoft all awarded on $9B DoD cloud contract
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- $51.85 /
+28.8 (+124.95%) - 12/19/22 TD Securities
- Maxar Technologies downgraded to Tender from Buy at TD Securities
- 12/19/22 RBC Capital
- Maxar Technologies downgraded to Sector Perform from Outperform at RBC Capital
- 12/19/22 BMO Capital
- Maxar Technologies price target raised to $53 from $27 at BMO Capital
- 12/19/22 Baird
- Maxar Technologies downgraded to Neutral from Outperform at Baird
- 12/08/22 Citi
- DoD contracts shows competitiveness of cloud industry, says Citi
- 11/30/22 Mizuho
- Alphabet price target lowered to $135 from $140 at Mizuho
- 11/29/22 Lake Street
- Google Health partnership 'significant positive' for iCAD, says Lake Street
- 11/23/22 JMP Securities
- Alphabet price target lowered to $132 from $145 at JMP Securities
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- $51.85 /
+28.8 (+124.95%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 12/17/22
- Amazon, Google among Barron's 10 favorite stocks for 2023
- 12/16/22
- Waymo driverless cars making airport pickups in Phoenix, Verge reports
- 12/09/22
- Google Ad Manager suffered an outage for more than 2 hours, WSJ reports
- 12/08/22
- EU says Google has to remove inaccurate data from search results, Reuters says
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- Sell these stocks now, proven algorithm says
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/15/22
- What You Missed On Wall Street On Thursday
- $51.85 /
+28.8 (+124.95%) - 12/16/22
- Fly Intel: Pre-market Movers
- 12/09/22
- What You Missed On Wall Street This Morning
- 12/07/22
- #SocialStocks: EU rules against Meta, despite attempts to settle
- 12/06/22
- What You Missed On Wall Street On Tuesday
- 12/06/22
- What You Missed On Wall Street This Morning
- 12/14/22
- Planet Labs PBC options imply 9.7% move in share price post-earnings
- 09/12/22
- Planet Labs PBC options imply 9.2% move in share price post-earnings
- 12/05/22
- Alphabet Class A call volume above normal and directionally bullish
- 11/04/22
- Notable open interest changes for November 4th
- 11/03/22
- Notable open interest changes for November 3rd
- 10/27/22
- Notable open interest changes for October 27th
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/15/22
- Trane commits to low-carbon steel purchases from Nucor, U.S. Steel
- 11/08/22
- U.S. Steel announces tentative agreement with United Steelworkers
- 09/15/22
- U.S. Steel slips after Q3 earnings guidance
- 08/16/22
- U.S. Steel, Equinor and Shell enter a cooperation agreement for clean energy hub
- 12/16/22
- Winnebago CEO says 2023 'critically important' for maintaining momentum
- 11/15/22
- Winnebago presents 2025 targets at investor day
- 11/15/22
- Winnebago to establish dedicated research, development facility
- 10/19/22
- Winnebago falls -10.4%
WBD Warner Bros. Discovery - 12/14/22
- Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023
- 12/06/22
- Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S.
- 11/14/22
- U.S. game content spending grew 2% y/y in October, says NPD
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/25/22
- Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital
- 10/26/22
- Travelzoo expects substantially higher revenue and profitability in Q4
- 08/01/22
- Travelzoo trading resumes
- 08/01/22
- Travelzoo trading halted, volatility trading pause
- 12/14/22
- Twitter shutting down newsletter platform Revue
- 12/12/22
- Twitter debuts Blue for Business, gold checkmarks for corporate entities
- 11/30/22
- Musk says Apple CEO never considered removing Twitter from App Store
- 12/16/22
- Trean Insurance to be acquired by Altaris Capital for $6.15 per share in cash
- 07/26/22
- Trean Insurance announces exclusive partnership with Beat Capital
- 11/10/22
- Steel Dynamics announces additional $1.5B share repurchase program
- 11/02/22
- Steel Dynamics selects Columbus, Mississippi, as location for aluminum mill
- 10/19/22
- Steel Dynamics says 'customer order entry activity continues to be healthy'
- 10/04/22
- Steel Dynamics completes acquisition of ROCA ACERO
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 09/29/22
- Sarepta submits BLA to FDA for accelerated approval of SRP-9001
- 09/14/22
- Sarepta prices $1B of convertible senior notes due 2027
- 12/16/22
- Planet Labs rises 10.2%
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 08/03/22
- New York Times sees FY22 CapEx approximately $55M
- 12/16/22
- Here's why Natera is jumping in afternoon trading
- 12/16/22
- ACMG publishes new guideline recommending NIPS for all pregnant individuals
- 12/09/22
- Natera: Published study highlights utility of Signatera test
- 12/06/22
- Natera publishes experience study in twin pregnancies in Prenatal Diagnosis
- 12/16/22
- Meta shutting down Cameo-like app Super
- 12/15/22
- Meta Platforms announces seven new solar projects in Georgia, Tennessee
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- $51.85 /
+28.8 (+124.95%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/15/22
- IMV Inc. to present initial patient data from VITALIZE trial
- 12/13/22
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
- 12/07/22
- IMV Inc. shareholders approve reverse stock split at 88%
- 09/30/22
- IMV Inc. provides update on VITALIZE study
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/29/22
- Stack Capital invests $8M in Locus Robotics
- 11/22/22
- Goldman Sachs Asset Management to pay $4M penalty to settle SEC charges
- 11/16/22
- Goldman Sachs exec sells $3.86M in common stock
- 12/15/22
- Guardant Health reports 'positive' results from ECLIPSE study
- 12/08/22
- Guardant Health announces collaboration with AstraZeneca
- 08/31/22
- Guardant Health expands strategic collaboration with Merck KGaA in oncology
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 12/16/22
- Arvinas appoints Everett Cunningham to board of directors
- 12/09/22
- Exact Sciences announces initial clinical validation data for POLAR
- 11/02/22
- Cathie Wood's ARK Investment bought 106.8K shares of Exact Sciences today
- 11/01/22
- Cathie Wood's ARK Investment bought 104K shares of Exact Sciences today
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 06/23/22
- Darden announces new $1B share repurchase program
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/09/22
- Disney+ Basic not currently available on Roku devices
- 12/08/22
- Disney announces ad-supported Disney+ plan available in the U.S.
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- 12/05/22
- Centene completes divestiture of Magellan Rx to Prime Therapeutics
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 12/13/22
- Avaya appoints RingCentral board nominee to board, says committed to partnership
- 11/07/22
- Avaya names Becky Roof named interim CFO amid Kieran McGrath retirement
- 09/06/22
- Avaya sees $23M-$26M in pre-tax charges from workforce reduction
- 08/16/22
- Avaya receives NYSE notice regarding late 10-Q fifling
- 07/17/22
- Fly Intel: Top five weekend stock stories
- 12/15/22
- Agilysys announces agreement with Marriott to deploy PMS software
- 12/15/22
- Adobe says regulatory process for Figma acquisition is proceeding as expected
- 12/06/22
- Adobe Stock to sell AI-generated images
- 11/27/22
- Fly Intel: Top five weekend stock stories
- 10/26/22
- Adobe director sells $5.4M in common stock
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/13/22
- American Airlines names Devon May Chief Financial Officer
- 12/09/22
- JetBlue, American Airlines add destinations taking off from New York, Boston
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- American Airlines: Pilot issues to take 2-3 years to work out
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/18/22 Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 10/24/22 DA Davidson
- Winnebago price target lowered to $54 from $60 at DA Davidson
- 10/03/22 MKM Partners
- Winnebago price target lowered to $56 from $67 at MKM Partners
- 08/09/22 MKM Partners
- Winnebago cut to Neutral at MKM Partners on valuation, worsened conditions
- 08/09/22 MKM Partners
- Winnebago downgraded to Neutral from Buy at MKM Partners
- 12/16/22 Stifel
- Adobe price target raised to $400 from $375 at Stifel
- 12/16/22 Evercore ISI
- Adobe price target raised to $425 from $350 at Evercore ISI
- 12/16/22 Morgan Stanley
- Adobe price target raised to $382 from $337 at Morgan Stanley
- 12/16/22 BMO Capital
- Adobe price target raised to $390 from $332 at BMO Capital
- $264.42 /
-16.66 (-5.93%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 12/14/22 Wedbush
- Darden upgraded to Outperform from Neutral at Wedbush
- 12/12/22 RBC Capital
- Darden price target raised to $155 from $144 at RBC Capital
- 12/09/22 KeyBanc
- Darden price target raised to $160 from $150 at KeyBanc
- 12/09/22 Barclays
- Darden price target raised to $146 from $136 at Barclays
- $51.85 /
+28.8 (+124.95%) - 12/16/22 Wells Fargo
- Maxar Technologies downgraded to Equal Weight from Overweight at Wells Fargo
- 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line at Evercore ISI after reserve review
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line from Outperform at Evercore ISI
- 03/29/22 JPMorgan
- Trean Insurance downgraded to Neutral from Overweight at JPMorgan
- 01/14/22 JMP Securities
- Trean Insurance price target lowered to $14 from $18 at JMP Securities
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/15/22 Morgan Stanley
- Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
- 11/10/22 Canaccord
- Meta Platforms price target lowered to $170 from $200 at Canaccord
- 11/09/22 Itau BBA
- Meta Platforms price target raised to $120 from $102 at Itau BBA
- 12/16/22 BTIG
- BTIG upgrades Agilysys to Buy on 'game-changing contract win'
- 12/16/22 BTIG
- Agilysys upgraded to Buy from Neutral at BTIG
- 12/15/22 Craig-Hallum
- Agilysys price target raised to $80 from $65 at Craig-Hallum
- 10/26/22 Craig-Hallum
- Craig-Hallum upgrades Agilysys to Buy, raises price target to $65
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- 12/08/22 Goldman Sachs
- AvalonBay downgraded to Neutral from Buy at Goldman Sachs
- 12/07/22 KeyBanc
- AvalonBay price target lowered to $193 from $237 at KeyBanc
- 12/02/22 Morgan Stanley
- AvalonBay downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/12/22 Morgan Stanley
- Disney price target lowered to $115 from $125 at Morgan Stanley
- 11/30/22 Atlantic Equities
- Atlantic Equities sees 'no easy fix' for Iger at Disney
- 11/22/22 Tigress Financial
- Disney price target lowered to $177 from $229 at Tigress Financial
- 11/21/22 JPMorgan
- JPMorgan 'reluctant to recommend chasing' Disney shares on rally
- 08/10/22 Goldman Sachs
- Goldman Sachs suspends rating on Avaya amid investigations
- 08/10/22 Barclays
- Avaya price target lowered to 50c from $2 at Barclays
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 12/14/22 Wells Fargo
- Goldman Sachs price target raised to $400 from $380 at Wells Fargo
- 10/19/22 BMO Capital
- Goldman Sachs price target lowered to $469 from $470 at BMO Capital
- 10/19/22 Barclays
- Goldman Sachs price target lowered to $410 from $450 at Barclays
- 10/19/22 Oppenheimer
- Goldman Sachs price target lowered to $477 from $483 at Oppenheimer
- 12/16/22 Goldman Sachs
- American Airlines resumed with a Neutral at Goldman Sachs
- 10/17/22 Citi
- American Airlines price target lowered to $15 from $16 at Citi
- 10/12/22 Barclays
- American Airlines price target lowered to $14 from $17 at Barclays
- 10/06/22 BofA
- American Airlines price target lowered to $7 from $8 at BofA
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
WBD Warner Bros. Discovery - 12/07/22 BofA
- Warner Bros. Discovery the 'best value in media,' says BofA
- 11/14/22 Spin-Off Research
- Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
- 11/10/22 Citi
- Warner Bros. Discovery price target lowered to $18 from $21 at Citi
- 11/08/22 Deutsche Bank
- Warner Bros. Discovery price target lowered to $35 from $48 at Deutsche Bank
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 12/16/22 Jefferies
- Guardant data missing expectations removes overhang on Exact, says Jefferies
- 11/14/22 Piper Sandler
- Exact Sciences price target raised to $50 from $40 at Piper Sandler
- 11/07/22 Raymond James
- Exact Sciences price target lowered to $60 from $70 at Raymond James
- 12/16/22 BofA
- Guardant Health price target raised to $70 from $65 at BofA
- 12/16/22 Cowen
- Guardant Health price target lowered to $70 from $83 at Cowen
- 12/16/22 Morgan Stanley
- Guardant's 'optical miss' presents 'compelling' entry point, says Morgan Stanley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 12/16/22 Piper Sandler
- ACMG recommends 22Q screening, Natera runs micro deletion, says Piper Sandler
- 12/16/22 Stephens
- ACMG updated recommendations a positive for Natera, Myriad, says Stephens
- 11/14/22 Credit Suisse
- Natera price target lowered to $55 from $70 at Credit Suisse
- 11/10/22 Raymond James
- CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
- 10/06/22 Goldman Sachs
- U.S. Steel price target lowered to $18 from $21 at Goldman Sachs
- 10/04/22 Morgan Stanley
- U.S. Steel said to be idling more capacity, says Morgan Stanley
- 09/16/22 Credit Suisse
- U.S. Steel price target lowered to $37 from $44 at Credit Suisse
- 07/27/22 GLJ Research
- Cleveland-Cliffs downgraded to Sell from Buy at GLJ Research
- 11/28/22 Barrington
- Travelzoo downgraded to Market Perform from Outperform at Barrington
- 08/08/22 Ascendiant
- Travelzoo upgraded to Buy from Hold at Ascendiant
- 07/29/22 Barrington
- Travelzoo price target lowered to $10 from $12 at Barrington
- 03/18/22 Ascendiant
- Travelzoo downgraded to Hold from Buy at Ascendiant
- 12/05/22 UBS
- Steel Dynamics downgraded to Neutral from Buy at UBS
- 11/14/22 BMO Capital
- Steel Dynamics price target raised to $100 from $89 at BMO Capital
- 10/21/22 BMO Capital
- Steel Dynamics price target raised to $89 from $77 at BMO Capital
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 12/16/22 UBS
- Sarepta upgraded to Buy at UBS ahead of 'highly likely' SRP-9001 approval
- 12/16/22 UBS
- Sarepta upgraded to Buy from Neutral at UBS
- 12/13/22 Cantor Fitzgerald
- Sarepta price target raised to $174 from $150 at Cantor Fitzgerald
- 11/28/22 Barclays
- Catalent had 483s cleared, removing overhang, says Barclays
- 12/15/22
- U.S. Steel sees Q4 adjusted EPS 58c-63c, consensus 43c
- 10/27/22
- U.S. Steel reports Q3 adjusted EPS $1.95, consensus $1.93
- 09/15/22
- U.S. Steel sees Q3 adjusted EPS $1.90-$1.95, consensus $1.90
- 07/28/22
- U.S. Steel reports Q2 EPS $3.86, consensus $3.87
- 12/16/22
- Winnebago reports Q1 adjusted EPS $2.07, consensus $1.78
- 10/19/22
- Winnebago reports Q4 adjusted EPS $3.02, consensus $2.76
- 06/22/22
- Winnebago reports Q3 adjusted EPS $4.13, consensus $2.96
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 12/16/22
- Travelzoo sees Q4 revenue $18.5M, consensus $17.6M
- 10/26/22
- Travelzoo reports Q3 EPS 6c, consensus 11c
- 07/27/22
- Travelzoo sees Q3 revenue higher year-over-year, consensus $21.36M
- 07/27/22
- Travelzoo reports Q2 EPS 8c, consensus 19c
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Trean Insurance sees Q4 loss ration consistent with Q3
- 11/02/22
- Trean Insurance raises FY22 revenue outlook to $278M-$383M from $255M-$265M
- 11/02/22
- Trean Insurance reports Q3 adjusted EPS 11c, consensus 9c
- 08/03/22
- Trean Insurance reports Q2 EPS 11c, consensus 7c
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 09/15/22
- Steel Dynamics sees Q3 adjusted EPS $5.33-$5.37, consensus $4.90
- 07/20/22
- Steel Dynamics reports Q2 adjusted EPS $6.73, consensus $6.05
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 08/02/22
- Sarepta reports Q2 EPS ($1.18), consensus ($1.18)
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 08/03/22
- New York Times reports Q2 adjusted EPS 24c, consensus 19c
- 11/08/22
- Natera raises FY22 revenue view to $810M-$830M from $805M-$825M
- 11/08/22
- Natera reports Q3 EPS ($1.25), consensus ($1.44)
- 08/04/22
- Natera raises FY22 revenue view to $805M-$825M from $790M-$810M
- 08/04/22
- Natera reports Q2 EPS ($1.50), consensus ($1.50)
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- $51.85 /
+28.8 (+124.95%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/10/22
- IMV Inc. reports Q3 EPS (11c), consensus (15c)
- 08/11/22
- IMV Inc. reports Q2 EPS (12c), consensus (12c)
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 08/04/22
- Guardant Health backs FY22 revenue $460M-$470M, consensus $465.29M
- 08/04/22
- Guardant Health reports Q2 adjusted EPS ($1.00), consensus ($1.21)
- 11/03/22
- Exact Sciences raises FY22 revenue view to $2.025B-$2.042B, consensus $2.01B
- 11/03/22
- Exact Sciences reports Q3 EPS (84c), consensus ($1.08)
- 08/02/22
- Exact Sciences lowers FY22 revenue view to $1.980B-$2.022B from $1.985B-$2.032B
- 08/02/22
- Exact Sciences reports Q2 EPS (94c), consensus ($1.07)
- 12/16/22
- Darden revises FY23 EPS view to $7.60-$8.00 from $7.40-$8.00, consensus $7.71
- 12/16/22
- Darden reports Q2 EPS $1.52, consensus $1.43
- 12/15/22
- Notable companies reporting before tomorrow's open
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 11/08/22
- Notable companies reporting after market close
- 08/10/22
- Disney reports Q3 EPS ex-items $1.09, consensus $1.00
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 10/25/22
- Centene raises FY22 adjusted EPS view to $5.65-$5.75 from $5.60-$5.70
- 08/09/22
- Avaya sees Q3 non-GAAP EPS 24c, consensus 5c
- 07/28/22
- Avaya sees Q3 revenue $575M-$580M, below previous guidance of $685M-$700M
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
- 07/27/22
- AvalonBay sees FY22 core FFO $9.76-$9.96, consensus $9.62
- 10/25/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $194.05M
- 10/25/22
- Agilysys reports Q1 adjusted EPS 24c, consensus 18c
- 07/26/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $192.84M
- 07/26/22
- Agilysys reports Q1 adjusted EPS 21c, consensus 18c
- 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 12/15/22
- Adobe sees Q1 adjusted EPS $3.65-$3.70, consensus $3.64
- 12/15/22
- Adobe reports Q4 adjusted EPS $3.60, consensus $3.50
- 12/15/22
- Notable companies reporting after market close
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 10/20/22
- American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c
- 10/20/22
- American Airlines reports Q3 EPS 69c, consensus 56c
- 10/19/22
- Notable companies reporting before tomorrow's open
|
On The Fly
| ShowHide Related Items >><< - 11/02/22
- Xometry CEO sells $1.2M in common stock
- 10/05/22
- Xometry CEO sells $1.17M in common stock
- 10/03/22
- Xometry appoints Matt Leibel as CTO, Brendan Sterne as CPO
- 08/25/22
- Xometry, CCBC announce public-private partnership for two-year scholarships
- 12/13/22
- Cathie Wood's ARK Investment bought 49K shares of Verve Therapeutics today
- 12/12/22
- Cathie Wood's ARK Investment bought 58K shares of Verve Therapeutics today
- 12/07/22
- Cathie Wood's ARK Investment bought 106K shares of Verve Therapeutics today
- 12/06/22
- Cathie Wood's ARK Investment bought 330.4K shares of Verve Therapeutics today
- 11/22/22
- Toast director Bennett sells 132,709 class A shares
- 11/11/22
- Toast Inc trading resumes
- 11/11/22
- Toast Inc trading halted, volatility trading pause
- 11/10/22
- Toast jumps 8% to $21.60 after Q3 results and FY22 guidance raise
- 12/13/22
- Nogin names Bonham-Carter as Chief Revenue Officer
- 11/29/22
- Shopify reports Black Friday Cyber Monday weekend sales up 19% y/y
- 11/28/22
- Shopify rises 8.8%
- 11/28/22
- Shopify rises 8.3%
- 12/16/22
- Sea Limited falls -9.9%
- 11/15/22
- Sea Limited rises 36.9%
- 11/15/22
- Sea Limited rises 29.5%
- 11/15/22
- Sea Limited rises 24.2%
RXRX Recursion Pharmaceuticals - 09/13/22
- Recursion Pharmaceuticals initiates two additional clinical trials
- 07/21/22
- Recursion Pharmaceuticals granted EU orphan drug designation for REC-4881
- 06/20/22
- Recursion announces initiation of Phase 2/3 trial for NF2-Mutated Meningiomas
RADI Radius Global Infrastructure - 11/30/22
- Radius Global Infrastructure trading resumes
- 11/30/22
- Radius Global jumps 13%, halted after Bloomberg report on takeover talks
- 11/30/22
- Radius Global Infrastructure trading halted, volatility trading pause
- 11/08/22
- Radius Global Infrastructure backs FY22 Acquisition CapEx view at least $400M
- 12/14/22
- Paysafe falls -9.9%
- 12/14/22
- Paysafe falls -8.5%
- 12/08/22
- Paysafe announces reverse stock split
- 11/29/22
- Paysafe enters new partnership with Virgin Voyages
- 12/16/22
- Planet Labs rises 10.2%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/12/22
- Mirati Therapeutics: FDA grants accelerated approval for KRAZATI
- 12/05/22
- Mirati Therapeutics announces results from KRYSTAL-7, KRYSTAL-1 trials
- 12/02/22
- Mirati Therapeutics provides update on Phase 3 SAPPHIRE study
- 11/22/22
- Mirati Therapeutics extends gain after volatility pause, now up 15%
- $51.49 /
+28.44 (+123.38%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
INM InMed Pharmaceuticals - 12/12/22
- InMed Pharmaceuticals engages Marcum LLP as auditor after KPMG resigns
- 12/12/22
- InMed Pharmaceuticals names Jonathan Tegge as interim CFO
- 11/18/22
- InMed Pharmaceuticals announces $6M private placement
- 11/17/22
- InMed Pharmaceuticals annouces Li promoted to VP of accounting, controller
- 12/06/22
- Freyr Battery, Nidec establish downstream joint venture
- 12/01/22
- Freyr Battery falls -12.7%
- 11/30/22
- Freyr Battery falls 13% to $11.92 after 13.5M share common stock offering
- 11/11/22
- Freyr Battery announces plan for Georgia Gigafactory
- 11/14/22
- Enviva names Thomas Meth CEO
- 11/02/22
- Enviva narrows FY22 adjusted EBITDA view to $240M-$260M from $230M-$270M
- 10/13/22
- ValueAct's Ubben bought 200,000 Enviva shares yesterday
- 10/12/22
- Enviva says shortseller report contains numerous errors
- 12/06/22
- Equinox Gold sells Solaris Resources shares for C$70.4M
- 10/19/22
- Equinox Gold announces results of Feasibility Study to expand Los Filos Mine
- 10/13/22
- Sandstorm Gold provides update on royalty portfolio
- 10/04/22
- Equinox Gold reports commercial production at Santa Luz Gold Mine
- 12/13/22
- Confluent appoints Shaun Clowes as chief product officer
- 12/09/22
- Carnival says delivery of Carnival Jubilee delayed
- 12/01/22
- Holland America Line reports 'record' Black Friday bookings in the U.S.
- 11/29/22
- Carnival says Cyber Monday bookings 50% above volume for Cyber Monday 2019
- 11/15/22
- Carnival falls 11% to $9.95 after $1B convertible senior notes offering
INM InMed Pharmaceuticals - 05/16/22 Roth MKM
- InMed Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
- 12/14/22 Needham
- Mirati Therapeutics initiated with a Hold at Needham
- 12/14/22 Barclays
- Mirati Therapeutics price target lowered to $90 from $169 at Barclays
- 12/13/22 Piper Sandler
- Mirati Therapeutics price target lowered to $68 from $87 at Piper Sandler
- 12/13/22 Piper Sandler
- Mirati Therapeutics price target raised to $87 from $84 at Piper Sandler
- 11/21/22 Cowen
- Sea Limited downgraded on lack of visibility at Cowen
- 11/21/22 Cowen
- Sea Limited downgraded to Market Perform from Outperform at Cowen
- 11/17/22 Morgan Stanley
- Sea Limited price target lowered to $95 from $116 at Morgan Stanley
- 11/16/22 Cowen
- Sea Limited price target lowered to $72 from $78 at Cowen
- 12/16/22 Wells Fargo
- Wells Fargo sees significant opportunity ahead for Toast
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 11/29/22 Wolfe Research
- Toast initiated with a Peer Perform at Wolfe Research
- 11/11/22 Needham
- Toast price target raised to $32 from $27 at Needham
- 12/09/22 SMBC Nikko
- Shopify price target raised to $45 from $40 at SMBC Nikko
- 12/08/22 Capital One
- Shopify initiated with an Equalweight at Capital One
- 12/08/22 UBS
- Shopify initiated with a Sell at UBS
- 12/08/22 Mizuho
- Shopify price target raised to $40 from $33 at Mizuho
- 12/07/22 National Bank
- Equinox Gold price target raised to C$5.50 from C$5 at National Bank
- 12/07/22 BMO Capital
- Equinox Gold price target raised to C$6.50 from C$6 at BMO Capital
- 11/07/22 BMO Capital
- Equinox Gold price target lowered to C$6 from C$7.50 at BMO Capital
- 11/04/22 National Bank
- Equinox Gold price target lowered to C$4 from C$5 at National Bank
- 11/03/22 DA Davidson
- Confluent price target lowered to $33 from $44 at DA Davidson
- 11/03/22 Credit Suisse
- Confluent price target lowered to $55 from $65 at Credit Suisse
- 11/03/22 Barclays
- Confluent price target lowered to $27 from $30 at Barclays
- 11/01/22 Citi
- Confluent price target lowered to $30 from $32 at Citi
- 12/14/22 Lake Street
- Xometry initiated with a Sell at Lake Street
- 12/13/22 Citi
- Xometry initiated with a Buy at Citi
- 11/11/22 UBS
- Xometry price target lowered to $45 from $55 at UBS
- 08/24/22 JPMorgan
- JPMorgan cuts Xometry target but still sees 46% upside potential
RADI Radius Global Infrastructure - 12/16/22 RBC Capital
- Radius Global Infrastructure initiated with a Sector Perform at RBC Capital
- 12/14/22 Exane BNP Paribas
- Radius Global Infrastructure initiated with an Outperform at Exane BNP Paribas
- 10/04/22 Raymond James
- Radius Global Infrastructure price target lowered to $17 from $21 at Raymond James
- 05/10/22 Raymond James
- Radius Global Infrastructure price target raised to $22 from $18 at Raymond James
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 08/31/22 Susquehanna
- Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see'
- 08/31/22 Susquehanna
- Paysafe downgraded to Neutral from Positive at Susquehanna
- 08/11/22 Credit Suisse
- Paysafe downgraded to Underperform from Neutral at Credit Suisse
- 08/10/22 RBC Capital
- Paysafe downgraded to Sector Perform from Outperform at RBC Capital
- 10/31/22 Cowen
- Cowen starts Freyr Battery at Outperform, sees 'less technology risk'
- 10/31/22 Cowen
- Freyr Battery initiated with an Outperform at Cowen
- 09/21/22 Morgan Stanley
- Freyr Battery price target raised to $26, named a 'Top Pick' at Morgan Stanley
- 09/01/22 BTIG
- Freyr Battery price target raised to $25 from $20 at BTIG
- 12/15/22 Goldman Sachs
- Verve Therapeutics initiated with a Sell at Goldman Sachs
- 12/05/22 Stifel
- Verve FDA request 'provides fodder for both bulls and bears,' says Stifel
- 12/02/22 Guggenheim
- Beam hold being lifted 'encouraging' for Verve Therapeutics, says Guggenheim
- 10/06/22 Credit Suisse
- Verve Therapeutics initiated with a Neutral at Credit Suisse
- 12/15/22 Barclays
- Carnival price target raised to $12 from $10 at Barclays
- 12/14/22 Stifel
- Carnival price target raised to $18 at Stifel, would buy ahead of Q4 report
- 12/12/22 Credit Suisse
- Credit Suisse keeps Outperform on Carnival, lowers price target to $19
- 12/06/22 JPMorgan
- Carnival assumed with a Neutral at JPMorgan
- 11/29/22 RBC Capital
- Enviva price target lowered to $63 from $76 at RBC Capital
- 10/20/22 JPMorgan
- Enviva price target lowered to $60 from $66 at JPMorgan
- 10/18/22 Raymond James
- Enviva upgraded to Strong Buy from Outperform at Raymond James
- 10/14/22 Citi
- Citi upgrades Enviva to Buy, says short report selloff overdone
RXRX Recursion Pharmaceuticals - 09/15/22 KeyBanc
- Recursion Pharmaceuticals initiated with an Overweight at KeyBanc
- 04/18/22 BofA
- Recursion Pharmaceuticals downgraded to Neutral from Buy at BofA
- 03/04/22 SVB Securities
- Recursion Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink
- $51.49 /
+28.44 (+123.38%) - 12/16/22 Wells Fargo
- Maxar Technologies downgraded to Equal Weight from Overweight at Wells Fargo
- 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 11/10/22
- Xometry sees Q4 revenue $104M-$106M, consensus $116.11M
- 11/10/22
- Xometry reports Q3 adjusted EPS (11c), consensus (22c)
- 08/10/22
- Xometry sees 2022 revenue $395M-$400M, consensus $397.09M
- 08/10/22
- Xometry sees Q3 revenue $102M-$104M, consensus $103.9M
- 11/07/22
- Verve Therapeutics reports Q3 EPS (79c), consensus (74c)
- 08/09/22
- Verve Therapeutics reports Q2 EPS (84c), consensus (63c)
- 11/10/22
- Toast raises FY22 revenue view to $2.692B-$2.722B from $2.62B-$2.66B
- 11/10/22
- Toast sees Q4 revenue $730M-$760M, consensus $731.31M
- 11/10/22
- Toast reports Q3 EPS (19c), consensus (9c)
- 08/11/22
- Toast raises FY22 revenue view to $2.62B-$2.66B, consensus $2.54B
- 10/27/22
- Shopify reports Q3 adjusted EPS (2c), consensus (10c)
- 10/26/22
- Notable companies reporting before tomorrow's open
- 07/27/22
- Shopify reports Q2 adjusted EPS (3c), consensus 3c
- 11/15/22
- Sea Limited reports Q3 EPS (66c), consensus ($1.09)
- 08/16/22
- Sea Limited suspends FY22 e-commerce GAAP guidance
- 08/16/22
- Sea Limited reports Q2 EPS ($1.03), consensus ($1.19)
RXRX Recursion Pharmaceuticals - 11/08/22
- Recursion Pharmaceuticals reports Q3 EPS (35c), consensus (38c)
- 08/09/22
- Recursion Pharmaceuticals reports Q2 EPS (38c), consensus (35c)
RADI Radius Global Infrastructure - 11/08/22
- Radius Global Infrastructure reports Q3 EPS 23c, consensus (26c)
- 11/10/22
- Paysafe sees Q4 revenue $370M-$378M, consensus $370.81M
- 11/10/22
- Paysafe raises FY22 revenue view to $1.48B-$1.49B from $1.47B-$1.49B
- 11/10/22
- Paysafe reports Q3 EPS 0c, consensus 0c
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/08/22
- Mirati Therapeutics reports Q3 EPS ($3.09), consensus ($3.48)
- 08/03/22
- Mirati Therapeutics reports Q2 EPS ($3.18), consensus ($3.49)
- $51.49 /
+28.44 (+123.38%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
INM InMed Pharmaceuticals - 11/11/22
- InMed Pharmaceuticals reports Q1 EPS ($4.06) vs. ($6.17) a year ago
- 09/23/22
- InMed Pharmaceuticals reports FY22 EPS ($33.17) vs. ($37.96) last year
- 11/14/22
- Freyr Battery reports Q3 EPS (80c), consensus (30c)
- 08/08/22
- Freyr Battery reports Q2 EPS 4c, consensus (26c)
- 11/02/22
- Enviva reports Q3 revenue $325.7M, consensus $352.16M
- 08/03/22
- Enviva backs FY22 adjusted EBITDA $230M-$270M
- 08/03/22
- Enviva reports Q2 revenue $296.3M, consensus $286.26M
- 06/21/22
- Enviva backs FY22 adjusted EBITDA view $230M-$270M
- 08/03/22
- Equinox Gold reports Q2 EPS (26c) vs. $1.19 last year
- 11/02/22
- Confluent raises FY22 EPS view to (65c)-(63c) from (73c)-(69c), consensus (70c)
- 11/02/22
- Confluent sees Q4 adjusted EPS (16c)-(14c), consensus (17c)
- 11/02/22
- Confluent reports Q3 adjusted EPS (13c), consensus (17c)
- 08/03/22
- Confluent raises FY22 EPS view to (73c)-(69c) from (79c)-(73c), consensus (75c)
- 09/30/22
- Carnival sees net loss, breakeven to slightly negative adjusted EBITDA in Q4
- 09/30/22
- Carnival reports Q3 EPS (65c), consensus (13c)
- 09/29/22
- Notable companies reporting before tomorrow's open
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/15/22
- Trane commits to low-carbon steel purchases from Nucor, U.S. Steel
- 11/08/22
- U.S. Steel announces tentative agreement with United Steelworkers
- 09/15/22
- U.S. Steel slips after Q3 earnings guidance
- 08/16/22
- U.S. Steel, Equinor and Shell enter a cooperation agreement for clean energy hub
- 12/16/22
- Winnebago CEO says 2023 'critically important' for maintaining momentum
- 11/15/22
- Winnebago presents 2025 targets at investor day
- 11/15/22
- Winnebago to establish dedicated research, development facility
- 10/19/22
- Winnebago falls -10.4%
WBD Warner Bros. Discovery - 12/14/22
- Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023
- 12/06/22
- Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S.
- 11/14/22
- U.S. game content spending grew 2% y/y in October, says NPD
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/25/22
- Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital
- 10/26/22
- Travelzoo expects substantially higher revenue and profitability in Q4
- 08/01/22
- Travelzoo trading resumes
- 08/01/22
- Travelzoo trading halted, volatility trading pause
- 12/14/22
- Twitter shutting down newsletter platform Revue
- 12/12/22
- Twitter debuts Blue for Business, gold checkmarks for corporate entities
- 11/30/22
- Musk says Apple CEO never considered removing Twitter from App Store
- 12/16/22
- Trean Insurance to be acquired by Altaris Capital for $6.15 per share in cash
- 07/26/22
- Trean Insurance announces exclusive partnership with Beat Capital
- 11/10/22
- Steel Dynamics announces additional $1.5B share repurchase program
- 11/02/22
- Steel Dynamics selects Columbus, Mississippi, as location for aluminum mill
- 10/19/22
- Steel Dynamics says 'customer order entry activity continues to be healthy'
- 10/04/22
- Steel Dynamics completes acquisition of ROCA ACERO
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 09/29/22
- Sarepta submits BLA to FDA for accelerated approval of SRP-9001
- 09/14/22
- Sarepta prices $1B of convertible senior notes due 2027
- 12/16/22
- Planet Labs rises 10.2%
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 08/03/22
- New York Times sees FY22 CapEx approximately $55M
- 12/16/22
- Meta shutting down Cameo-like app Super
- 12/15/22
- Meta Platforms announces seven new solar projects in Georgia, Tennessee
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- $51.43 /
+28.38 (+123.12%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/15/22
- IMV Inc. to present initial patient data from VITALIZE trial
- 12/13/22
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
- 12/07/22
- IMV Inc. shareholders approve reverse stock split at 88%
- 09/30/22
- IMV Inc. provides update on VITALIZE study
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/29/22
- Stack Capital invests $8M in Locus Robotics
- 11/22/22
- Goldman Sachs Asset Management to pay $4M penalty to settle SEC charges
- 11/16/22
- Goldman Sachs exec sells $3.86M in common stock
- $28.41 /
-12.84 (-31.13%) - 12/15/22
- Guardant Health reports 'positive' results from ECLIPSE study
- 12/08/22
- Guardant Health announces collaboration with AstraZeneca
- 08/31/22
- Guardant Health expands strategic collaboration with Merck KGaA in oncology
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 07/19/22
- Gencor Industries transfers common stock listing to NYSE American
- 12/16/22
- Arvinas appoints Everett Cunningham to board of directors
- 12/09/22
- Exact Sciences announces initial clinical validation data for POLAR
- 11/02/22
- Cathie Wood's ARK Investment bought 106.8K shares of Exact Sciences today
- 11/01/22
- Cathie Wood's ARK Investment bought 104K shares of Exact Sciences today
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 06/23/22
- Darden announces new $1B share repurchase program
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- 12/05/22
- Centene completes divestiture of Magellan Rx to Prime Therapeutics
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 12/13/22
- Avaya appoints RingCentral board nominee to board, says committed to partnership
- 11/07/22
- Avaya names Becky Roof named interim CFO amid Kieran McGrath retirement
- 09/06/22
- Avaya sees $23M-$26M in pre-tax charges from workforce reduction
- 08/16/22
- Avaya receives NYSE notice regarding late 10-Q fifling
- 07/17/22
- Fly Intel: Top five weekend stock stories
- 12/15/22
- Apollo funds provide $200M to WEC Energy renewable porfolio
- 11/29/22
- Atlas Air Worldwide shareholders approve of proposed acquisition by Apollo
- 11/29/22
- Apollo Global appoints Wooden as Partner, Chief Public Pension Strategist
- 11/28/22
- Taboola, Yahoo enter 30-year commercial agreement
- 12/15/22
- Agilysys announces agreement with Marriott to deploy PMS software
- $339.25 /
+10.36 (+3.15%) - 12/15/22
- Adobe says regulatory process for Figma acquisition is proceeding as expected
- 12/06/22
- Adobe Stock to sell AI-generated images
- 11/27/22
- Fly Intel: Top five weekend stock stories
- 10/26/22
- Adobe director sells $5.4M in common stock
- $264.91 /
-16.17 (-5.75%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/13/22
- American Airlines names Devon May Chief Financial Officer
- 12/09/22
- JetBlue, American Airlines add destinations taking off from New York, Boston
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- American Airlines: Pilot issues to take 2-3 years to work out
- $339.25 /
+10.36 (+3.15%) - 12/16/22 Stifel
- Adobe price target raised to $400 from $375 at Stifel
- 12/16/22 Evercore ISI
- Adobe price target raised to $425 from $350 at Evercore ISI
- 12/16/22 Morgan Stanley
- Adobe price target raised to $382 from $337 at Morgan Stanley
- 12/16/22 BMO Capital
- Adobe price target raised to $390 from $332 at BMO Capital
- $264.91 /
-16.17 (-5.75%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 12/14/22 Wedbush
- Darden upgraded to Outperform from Neutral at Wedbush
- 12/12/22 RBC Capital
- Darden price target raised to $155 from $144 at RBC Capital
- 12/09/22 KeyBanc
- Darden price target raised to $160 from $150 at KeyBanc
- 12/09/22 Barclays
- Darden price target raised to $146 from $136 at Barclays
- $51.43 /
+28.38 (+123.12%) - 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 11/07/22 BMO Capital
- Maxar Technologies price target lowered to $27 from $32 at BMO Capital
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line at Evercore ISI after reserve review
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line from Outperform at Evercore ISI
- 03/29/22 JPMorgan
- Trean Insurance downgraded to Neutral from Overweight at JPMorgan
- 01/14/22 JMP Securities
- Trean Insurance price target lowered to $14 from $18 at JMP Securities
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/15/22 Morgan Stanley
- Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
- 11/10/22 Canaccord
- Meta Platforms price target lowered to $170 from $200 at Canaccord
- 11/09/22 Itau BBA
- Meta Platforms price target raised to $120 from $102 at Itau BBA
- 12/16/22 BTIG
- BTIG upgrades Agilysys to Buy on 'game-changing contract win'
- 12/16/22 BTIG
- Agilysys upgraded to Buy from Neutral at BTIG
- 12/15/22 Craig-Hallum
- Agilysys price target raised to $80 from $65 at Craig-Hallum
- 10/26/22 Craig-Hallum
- Craig-Hallum upgrades Agilysys to Buy, raises price target to $65
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- 12/08/22 Goldman Sachs
- AvalonBay downgraded to Neutral from Buy at Goldman Sachs
- 12/07/22 KeyBanc
- AvalonBay price target lowered to $193 from $237 at KeyBanc
- 12/02/22 Morgan Stanley
- AvalonBay downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/10/22 Goldman Sachs
- Goldman Sachs suspends rating on Avaya amid investigations
- 08/10/22 Barclays
- Avaya price target lowered to 50c from $2 at Barclays
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 12/14/22 Wells Fargo
- Goldman Sachs price target raised to $400 from $380 at Wells Fargo
- 10/19/22 BMO Capital
- Goldman Sachs price target lowered to $469 from $470 at BMO Capital
- 10/19/22 Barclays
- Goldman Sachs price target lowered to $410 from $450 at Barclays
- 10/19/22 Oppenheimer
- Goldman Sachs price target lowered to $477 from $483 at Oppenheimer
- 12/16/22 Goldman Sachs
- American Airlines resumed with a Neutral at Goldman Sachs
- 10/17/22 Citi
- American Airlines price target lowered to $15 from $16 at Citi
- 10/12/22 Barclays
- American Airlines price target lowered to $14 from $17 at Barclays
- 10/06/22 BofA
- American Airlines price target lowered to $7 from $8 at BofA
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
WBD Warner Bros. Discovery - 12/07/22 BofA
- Warner Bros. Discovery the 'best value in media,' says BofA
- 11/14/22 Spin-Off Research
- Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
- 11/10/22 Citi
- Warner Bros. Discovery price target lowered to $18 from $21 at Citi
- 11/08/22 Deutsche Bank
- Warner Bros. Discovery price target lowered to $35 from $48 at Deutsche Bank
- 11/15/22 Deutsche Bank
- Apollo Global price target raised to $83 from $81 at Deutsche Bank
- 11/03/22 Barclays
- Apollo Global price target raised to $73 from $65 at Barclays
- 11/03/22 Deutsche Bank
- Apollo Global price target raised to $81 from $78 at Deutsche Bank
- 10/19/22 UBS
- Apollo Global price target lowered to $55 from $60 at UBS
- 11/23/22 Morgan Stanley
- EQT AB resumed with an Equal Weight at Morgan Stanley
- 11/01/22 Goldman Sachs
- EQT AB reinstated with a Buy at Goldman Sachs
- 10/27/22 Credit Suisse
- EQT AB initiated with an Underperform at Credit Suisse
- 10/19/22 Societe Generale
- EQT AB price target lowered to SEK 230 from SEK 250 at Societe Generale
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 12/16/22 Jefferies
- Guardant data missing expectations removes overhang on Exact, says Jefferies
- 11/14/22 Piper Sandler
- Exact Sciences price target raised to $50 from $40 at Piper Sandler
- 11/07/22 Raymond James
- Exact Sciences price target lowered to $60 from $70 at Raymond James
- $28.41 /
-12.84 (-31.13%) - 12/16/22 BofA
- Guardant Health price target raised to $70 from $65 at BofA
- 12/16/22 Cowen
- Guardant Health price target lowered to $70 from $83 at Cowen
- 12/16/22 Morgan Stanley
- Guardant's 'optical miss' presents 'compelling' entry point, says Morgan Stanley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 10/06/22 Goldman Sachs
- U.S. Steel price target lowered to $18 from $21 at Goldman Sachs
- 10/04/22 Morgan Stanley
- U.S. Steel said to be idling more capacity, says Morgan Stanley
- 09/16/22 Credit Suisse
- U.S. Steel price target lowered to $37 from $44 at Credit Suisse
- 07/27/22 GLJ Research
- Cleveland-Cliffs downgraded to Sell from Buy at GLJ Research
- 11/28/22 Barrington
- Travelzoo downgraded to Market Perform from Outperform at Barrington
- 08/08/22 Ascendiant
- Travelzoo upgraded to Buy from Hold at Ascendiant
- 07/29/22 Barrington
- Travelzoo price target lowered to $10 from $12 at Barrington
- 03/18/22 Ascendiant
- Travelzoo downgraded to Hold from Buy at Ascendiant
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/18/22 Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 10/24/22 DA Davidson
- Winnebago price target lowered to $54 from $60 at DA Davidson
- 10/03/22 MKM Partners
- Winnebago price target lowered to $56 from $67 at MKM Partners
- 08/09/22 MKM Partners
- Winnebago cut to Neutral at MKM Partners on valuation, worsened conditions
- 08/09/22 MKM Partners
- Winnebago downgraded to Neutral from Buy at MKM Partners
- 12/05/22 UBS
- Steel Dynamics downgraded to Neutral from Buy at UBS
- 11/14/22 BMO Capital
- Steel Dynamics price target raised to $100 from $89 at BMO Capital
- 10/21/22 BMO Capital
- Steel Dynamics price target raised to $89 from $77 at BMO Capital
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 12/16/22 UBS
- Sarepta upgraded to Buy at UBS ahead of 'highly likely' SRP-9001 approval
- 12/16/22 UBS
- Sarepta upgraded to Buy from Neutral at UBS
- 12/13/22 Cantor Fitzgerald
- Sarepta price target raised to $174 from $150 at Cantor Fitzgerald
- 11/28/22 Barclays
- Catalent had 483s cleared, removing overhang, says Barclays
- 12/15/22
- U.S. Steel sees Q4 adjusted EPS 58c-63c, consensus 43c
- 10/27/22
- U.S. Steel reports Q3 adjusted EPS $1.95, consensus $1.93
- 09/15/22
- U.S. Steel sees Q3 adjusted EPS $1.90-$1.95, consensus $1.90
- 07/28/22
- U.S. Steel reports Q2 EPS $3.86, consensus $3.87
- 12/16/22
- Winnebago reports Q1 adjusted EPS $2.07, consensus $1.78
- 10/19/22
- Winnebago reports Q4 adjusted EPS $3.02, consensus $2.76
- 06/22/22
- Winnebago reports Q3 adjusted EPS $4.13, consensus $2.96
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 12/16/22
- Travelzoo sees Q4 revenue $18.5M, consensus $17.6M
- 10/26/22
- Travelzoo reports Q3 EPS 6c, consensus 11c
- 07/27/22
- Travelzoo sees Q3 revenue higher year-over-year, consensus $21.36M
- 07/27/22
- Travelzoo reports Q2 EPS 8c, consensus 19c
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Trean Insurance sees Q4 loss ration consistent with Q3
- 11/02/22
- Trean Insurance raises FY22 revenue outlook to $278M-$383M from $255M-$265M
- 11/02/22
- Trean Insurance reports Q3 adjusted EPS 11c, consensus 9c
- 08/03/22
- Trean Insurance reports Q2 EPS 11c, consensus 7c
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 09/15/22
- Steel Dynamics sees Q3 adjusted EPS $5.33-$5.37, consensus $4.90
- 07/20/22
- Steel Dynamics reports Q2 adjusted EPS $6.73, consensus $6.05
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 08/02/22
- Sarepta reports Q2 EPS ($1.18), consensus ($1.18)
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 08/03/22
- New York Times reports Q2 adjusted EPS 24c, consensus 19c
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- $51.43 /
+28.38 (+123.12%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/10/22
- IMV Inc. reports Q3 EPS (11c), consensus (15c)
- 08/11/22
- IMV Inc. reports Q2 EPS (12c), consensus (12c)
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- $28.41 /
-12.84 (-31.13%) - 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 08/04/22
- Guardant Health backs FY22 revenue $460M-$470M, consensus $465.29M
- 08/04/22
- Guardant Health reports Q2 adjusted EPS ($1.00), consensus ($1.21)
- 12/16/22
- Gencor Industries reports 2022 EPS (3c) vs. 39c last year
- 08/12/22
- Gencor Industries reports Q3 EPS (7c) vs. 16c last year
- 11/03/22
- Exact Sciences raises FY22 revenue view to $2.025B-$2.042B, consensus $2.01B
- 11/03/22
- Exact Sciences reports Q3 EPS (84c), consensus ($1.08)
- 08/02/22
- Exact Sciences lowers FY22 revenue view to $1.980B-$2.022B from $1.985B-$2.032B
- 08/02/22
- Exact Sciences reports Q2 EPS (94c), consensus ($1.07)
- 12/16/22
- Darden revises FY23 EPS view to $7.60-$8.00 from $7.40-$8.00, consensus $7.71
- 12/16/22
- Darden reports Q2 EPS $1.52, consensus $1.43
- 12/15/22
- Notable companies reporting before tomorrow's open
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 10/25/22
- Centene raises FY22 adjusted EPS view to $5.65-$5.75 from $5.60-$5.70
- 08/09/22
- Avaya sees Q3 non-GAAP EPS 24c, consensus 5c
- 07/28/22
- Avaya sees Q3 revenue $575M-$580M, below previous guidance of $685M-$700M
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
- 07/27/22
- AvalonBay sees FY22 core FFO $9.76-$9.96, consensus $9.62
- 11/02/22
- Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year
- 11/01/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02
- 10/25/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $194.05M
- 10/25/22
- Agilysys reports Q1 adjusted EPS 24c, consensus 18c
- 07/26/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $192.84M
- 07/26/22
- Agilysys reports Q1 adjusted EPS 21c, consensus 18c
- $339.25 /
+10.36 (+3.15%) - 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 12/15/22
- Adobe sees Q1 adjusted EPS $3.65-$3.70, consensus $3.64
- 12/15/22
- Adobe reports Q4 adjusted EPS $3.60, consensus $3.50
- 12/15/22
- Notable companies reporting after market close
- $264.91 /
-16.17 (-5.75%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 10/20/22
- American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c
- 10/20/22
- American Airlines reports Q3 EPS 69c, consensus 56c
- 10/19/22
- Notable companies reporting before tomorrow's open
|
Hot Stocks
|
Planet Labs is up 10.2%,… Planet Labs is up 10.2%, or 51c to $5.43. ShowHide Related Items >><< - 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 11/15/22
- Microsoft, Planet to provide AI and satellite data for African climate projects
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 12/15/22
- Fly Intel: Pre-market Movers
- 11/18/22
- Sell these stocks now, proven algorithm says
- 12/14/22
- Planet Labs PBC options imply 9.7% move in share price post-earnings
- 09/12/22
- Planet Labs PBC options imply 9.2% move in share price post-earnings
|
Hot Stocks
|
Shares of several… Shares of several companies involved in geospatial intelligence that own or operate small satellite constellations, such as BlackSky Technology (BKSY), Planet Labs (PL), and Terran Orbital (LLAP), are moving higher in morning trading after Maxar Technologies (MAXR) agreed to be acquired by Advent International in an all-cash transaction that values Maxar at an enterprise value of approximately $6.4B or $53 per share in cash. In pre-market trading after the deal announcement, shares of Maxar have more than doubled to trading near $51 per share, while BlackSky has risen nearly 9% to $2 per share, Planet Labs is up 7.5% to $5.30 and Terran Orbital has advanced 4% to $1.47. ShowHide Related Items >><< - 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 11/15/22
- Microsoft, Planet to provide AI and satellite data for African climate projects
- 11/11/22
- Planet Labs expands board
- 12/16/22
- Maxar Technologies to be acquired by Advent International for $6.4B in cash
- 12/05/22
- Maxar Technologies: NOAA modifies Maxar's remote sensing license
- 11/23/22
- Maxar Technologies falls -10.5%
- 11/22/22
- EchoStar, Maxar Technologies amend pact for Hughes JUPITER 3 production
- 12/06/22
- Terran Orbital names Santina Michel SVP, Chief Human Resources Officer
- 11/14/22
- Terran Orbital-developed CAPSTONE enters NRHO around the moon
- 11/09/22
- Terran Orbital provides operational outlook
- 10/31/22
- Terran Orbital rises 23.8%
- 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 10/26/22
- BlackSky names Jon Kirchner chief product officer
- 10/25/22
- BlackSky awarded 1 year $10M contract for HF imagery services in Asia
- 09/19/22
- BlackSky wins $13.8M in orders from NGA contract
- 11/08/22 Deutsche Bank
- BlackSky initiated with a Buy at Deutsche Bank
- 10/11/22 Credit Suisse
- BlackSky initiated with Outperform on growth momentum at Credit Suisse
- 10/11/22 Credit Suisse
- BlackSky initiated with an Outperform at Credit Suisse
- 07/26/22 Lake Street
- BlackSky initiated with a Buy at Lake Street
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 11/10/22 Canaccord
- Terran Orbital price target raised to $15 from $14 at Canaccord
- 11/01/22 Canaccord
- Terran Orbital price target lowered to $14 from $17 at Canaccord
- 10/05/22 Canaccord
- Terran Orbital price target lowered to $17 from $18 at Canaccord
- 10/05/22 Benchmark
- M&A in space manufacturing 'validation' for Terran Orbital, says Benchmark
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 11/07/22 BMO Capital
- Maxar Technologies price target lowered to $27 from $32 at BMO Capital
- 11/04/22 Canaccord
- Maxar Technologies price target lowered to $38 from $40 at Canaccord
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/09/22
- Terran Orbital reports Q3 EPS (19c), consensus (22c)
- 11/08/22
- BlackSky sees FY22 revenue at upper end of $62M-$66M range, consensus $65.32M
- 11/08/22
- BlackSky reports Q3 EPS (11c), consensus (20c)
- 12/15/22
- What You Missed On Wall Street On Thursday
- 12/15/22
- What You Missed On Wall Street This Morning
- 12/15/22
- Fly Intel: Pre-market Movers
- 11/18/22
- Sell these stocks now, proven algorithm says
- 12/16/22
- Fly Intel: Pre-market Movers
- 11/23/22
- What You Missed On Wall Street On Wednesday
- 11/23/22
- What You Missed On Wall Street This Morning
- 06/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/31/22
- What You Missed On Wall Street On Monday
- 10/31/22
- What You Missed On Wall Street This Morning
- 08/15/22
- What You Missed On Wall Street On Monday
- 08/15/22
- What You Missed On Wall Street This Morning
- 11/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/14/22
- Planet Labs PBC options imply 9.7% move in share price post-earnings
- 09/12/22
- Planet Labs PBC options imply 9.2% move in share price post-earnings
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 10/26/22
- Kioxia, Western Digital open semiconductor fabrication facility Fab7 in Japan
- 08/31/22
- Western Digital, Micron lower in pre-market after Seagate guidance cut
- 08/15/22
- Elliott buys Pinterest, exits Twitter in Q2
- 08/05/22
- Western Digital drops 8% to $45.80 after Q1 guidance misses estimates
- 12/15/22
- Verizon Frontline Crisis Response team deployed nearly 700 times in 2022
- 12/12/22
- Verizon Public Sector collaborates with Veterans Health Administration's NCCHI
- 12/07/22
- Enthusiast Gaming announces Verizon, Xbox as NFL TNG sponsors
- 11/09/22
- Trade Desk jumps 8% to $47.01 after Q3 results beat estimates
- 10/04/22
- Trade Desk sees long-term adjusted EBITDA at 40%
- 08/09/22
- Trade Desk jumps 16% to $63.50 after Q3 revenue guidance beats estimates
- 07/28/22
- Trade Desk Chief Data Officer Michelle Hulst to step down
- 12/15/22
- Elon Musk sells 22M shares of Tesla for $3.58B
- 12/15/22
- EU passenger car registrations up 16.3% in November
- 12/07/22
- Interest rates, slow economy weigh on U.S. auto dealers, Cox Automotive says
- 12/06/22
- Vietnam-based EV maker VinFast plans for U.S. IPO
- 12/13/22
- TransUnion to sell G2, LCI and Fintellix for $176M
- 11/29/22
- TransUnion's Q3 industry report shows growth in Canadian credit market
- 11/16/22
- TransUnion announces Q3 attempted rally suppressed by Hurricane Ian
- 11/10/22
- TransUnion includes high-demand health audiences in TruAudience Data Marketplace
- 12/15/22
- Third Harmonic Bio discontinues Phase 1b study of THB001
- 12/06/22
- AT&T COO says company continues to see healthy demand
- 11/17/22
- AT&T sees elevated investment levels in 2022-2023, moderated spending in 2024
- 11/10/22
- Brightline Interactive to power technology demonstration with AT&T
- 10/25/22
- User reports indicate problems at AT&T, says Downdetector
SPY SPDR S&P 500 ETF Trust - 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/07/22
- SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace
- 12/15/22
- Snap falls -6.7%
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- 12/06/22
- Snap, H&M partner for digital fashion collection
- 12/15/22
- Roblox falls -16.5%
- 12/15/22
- Roblox falls -12.7%
- 12/15/22
- Roblox falls -11.0%
- 12/15/22
- Roblox reports November DAUs 56.7M, up 15%
- 12/15/22
- Plug Power, Nikola announce collaboration to push hydrogen economy forward
- 12/15/22
- Nikola, Plug Power partner for green hydrogen development
- 10/19/22
- Plug Power, FreezPak logistics expand agreement to supply fuel cells
- 10/19/22
- Plug Power, Olin launch joint venture for 15-ton-per-day hydrogen plant
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 11/15/22
- Microsoft, Planet to provide AI and satellite data for African climate projects
- 11/11/22
- Planet Labs expands board
- 12/14/22
- IonQ hires Rima Alameddine as Chief Revenue Officer
- 12/07/22
- KULR Technology expands KULR VIBE offering with AI server platform
- 11/23/22
- Third quarter CPU shipments down 18.6% compared to Q321, JPR says
- 11/17/22
- Lockheed, Nvidia to build digital twin of current global weather conditions
- 12/07/22
- Novavax Nuvaxovid COVID-19 vaccine approved in Canada for ages 12-17
- 11/29/22
- Novavax's COVID-19 vaccine issued Emergency Use update by WHO
- 11/18/22
- Novavax's COVID-19 vaccine authorized in Canada as booster in adults
- 11/09/22
- Novavax' Nuvaxovid authorized in U.K. for use as booster in adults
- $134.11 /
-13.885 (-9.38%) - 12/15/22
- Nucor to expand Towers & Structures business
- 12/14/22
- Nucor increases dividend to 51c per share
- 12/08/22
- Nucor makes equity investment in Electra
- 11/15/22
- Nucor joining the UN's 24/7 Carbon-Free Energy Global Compact
- 12/01/22
- Nikola's Phoenix Hydrogen Hub project included in Phase II of DoE loan process
- 11/18/22
- Nikola: Pablo Koziner, President, Commercial, to depart in December
- $290.35 /
-27.83 (-8.75%) - 12/14/22
- Verizon announces early access to +play beta
- 12/06/22
- Netflix CEO Sarandos sees multiple ad tiers over time
- 12/01/22
- Enthusiast Gaming, Netflix enter content partnership for Geeked: Toon-in
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 11/22/22
- New Fortress Energy finalizes agreements with Pemex
- 10/28/22
- New Fortress Energy finalizes agreement with Comision Federal de Electricidad
- 08/04/22
- New Fortress Energy enters 120MW green hydrogen plant deal with Plug Power
- 08/04/22
- Plug Power selected by New Fortress Energy for 120 MW green hydrogen plant
- 12/15/22
- National Instruments appoints Daniel Berenbaum as CFO
- 12/06/22
- Micron ships Micron 2550 NVMe SSD to global PC OEM customers
- 11/29/22
- Micron CFO says pricing has trended 'well below' expectations
- 11/16/22
- Micron down 5% after warning outlook for 2023 has weakened
- 09/22/22
- Lennar: Q3 cancellation rate 'slightly above' historical average
- 09/22/22
- Lennar will complete planned spinoff by year-end, says Miller
- 09/22/22
- Lennar: Interest rate movements were 'sudden,' 'adjusted quickly'
- 09/22/22
- Lennar: Focused on bringing down production costs
- 12/15/22
- Lennar says postponing planned spin-off until more favorable conditions
- 12/15/22
- Lennar says inventory being 'carefully managed'
- 12/15/22
- Lennar expects cancellation rates to normalize 'in near future'
- 12/14/22
- Lennar says 'our balance sheet has never been in a stronger position'
- 11/14/22
- Jabil opens new design center in Poland
- 11/04/22
- Jabil says Kenny Wilson to succeed Mark Mondello as CEO on May 1, 2023
- 11/01/22
- Jabil exec Smith sells 17,618 common shares
- 09/27/22
- Jabil announces $1B share repurchase program
- 12/15/22
- HEXO notes company's 'ability to continue as a going concern'
- 12/15/22
- Hexo CFO says 'substantially lowered' overhead costs
- 12/14/22
- Hexo announces share consolidation
- 12/06/22
- Hexo announces repayment of 8% unsecured convertible debentures
- 12/15/22
- FIS commences comprehensive assessment, adds new Independent Director to Board
- 12/15/22
- FIS says Stephanie Ferris to succeed Gary Norcross as CEO
- 11/22/22
- FIS up nearly 3% after Bloomberg report on job cutting plans
- 10/24/22
- FIS announces Walmart joins Premium Payback
- 12/07/22
- Ford reports chief marketing officer Deering departing company
- 12/06/22
- Ford, SK On break ground on BlueOval SK BatteryPark to produce EV batteries
- 12/14/22
- Delta Air Lines: December business 'off trend,' sees improvement in January
- 12/14/22
- Delta sees $30B of travel spending in 2023
- 12/14/22
- Delta sees February revenue better than January, March better than February
- 12/14/22
- Delta sees January revenue 'significantly' better than December
- 12/15/22
- Amazon confirms deal with Crystal Dynamics to publish new 'Tomb Raider' game
- 12/14/22
- Amazon Ads providing U.S. advertisers free access to Shutterstock library
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/09/22
- Amazon, Bandai Namco partner over release of 'Blue Protocol' in 2023
- 12/15/22
- AbCellera, AbbVie enter strategic collaboration
- 12/01/22
- AbCellera, Rallybio enter pact for novel antibody-based therapeutics
- 11/30/22
- FDA announces bebtelovimab not currently authorized in any U.S. region
- 11/30/22
- AbCellera down 7% after FDA announces bebtelovimab not authorized in U.S.
- 12/14/22
- Exicure announces termination of collaboration agreements with AbbVie, Ipsen
- 12/11/22
- AbbVie presents data evaluating epcoritamab across B-cell lymphomas
- 12/06/22
- AbbVie collaborates with HotSpot Therapeutics for autoimmune diseases
- 06/22/22
- President Biden calls on Congress to suspend federal gas tax
- 12/15/22 Wedbush
- Pain continues with Twitter 'funding nightmare,' says Wedbush
- 12/15/22 RBC Capital
- Tesla price target lowered to $225 from $325 at RBC Capital
- 12/14/22 Citi
- Citi explains why Tesla shares sold off on Tuesday
- 12/13/22 Goldman Sachs
- Tesla price target lowered to $235 from $305 at Goldman Sachs
- $290.35 /
-27.83 (-8.75%) - 12/14/22 Jefferies
- Netflix price target raised to $310 from $250 at Jefferies
- 12/09/22 Cowen
- Netflix price target raised to $405 at Cowen, named a 'Best Idea for 2023'
- 12/09/22 Wells Fargo
- Wells Fargo upgrades Netflix shares on 'more ways to win' in 2023
- 12/09/22 Wells Fargo
- Netflix upgraded to Overweight from Equal Weight at Wells Fargo
- 12/15/22 Wolfe Research
- Activist involvement at FIS doesn't come as a surprise, says Wolfe Research
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 12/09/22 Jefferies
- FIS downgraded to Hold from Buy at Jefferies
- 11/29/22 Bernstein
- Bernstein sees FIS as 'good candidate' for potential activist involvement
- 12/14/22 Barclays
- Lennar upgraded to Overweight from Equal Weight at Barclays
- 12/06/22 BTIG
- Lennar price target raised to $101 from $92 at BTIG
- 12/01/22 Citi
- Lennar resumed with a Buy at Citi
- 11/22/22 JPMorgan
- Lennar price target raised to $97 from $73 at JPMorgan
- 10/31/22 JPMorgan
- Central bank tightening has likely peaked, says JPMorgan
- 10/07/22 JPMorgan
- JPMorgan changes November rate hike assumption after jobs data
- 09/26/22 JPMorgan
- JPMorgan says stocks oversold amid 'encouraging' inflation signs
- 09/23/22 Goldman Sachs
- Goldman Sachs lowers S&P 500 year-end target to 3,600
SPY SPDR S&P 500 ETF Trust - 12/15/22 Goldman Sachs
- Western Digital downgraded to Sell from Neutral at Goldman Sachs
- 11/29/22 Mizuho
- Western Digital price target lowered to $38 from $40 at Mizuho
- 10/31/22 Citi
- Western Digital price target lowered to $45 from $60 at Citi
- 10/31/22 Baird
- Western Digital price target lowered to $50 from $55 at Baird
- 12/15/22 HSBC
- Nvidia initiated with a Reduce at HSBC
- 12/14/22 Deutsche Bank
- Nvidia price target raised to $170 from $150 at Deutsche Bank
- 12/12/22 Cowen
- Nvidia price target raised to $220 from $200 at Cowen
- 12/08/22 Tigress Financial
- Nvidia price target lowered to $250 from $310 at Tigress Financial
- 12/15/22 Morgan Stanley
- Verizon upgraded to Overweight from Equal Weight at Morgan Stanley
- 12/15/22 Morgan Stanley
- AT&T downgraded to Equal Weight from Overweight at Morgan Stanley
- 10/26/22 Morgan Stanley
- Verizon price target lowered to $41 from $58 at Morgan Stanley
- 10/25/22 Citi
- Verizon price target lowered to $39 from $48 at Citi
- 12/08/22 Argus
- Argus upgrades AT&T to Buy amid focus on wireless and broadband expansion
- 12/08/22 Argus
- AT&T upgraded to Buy from Hold at Argus
- 11/14/22 Wells Fargo
- Dycom price target lowered to $120 from $130 at Wells Fargo
- 12/15/22 Jefferies
- Snap downgraded to Hold at Jefferies, Street 'overly optimistic' on digital ads
- 12/15/22 Jefferies
- Snap downgraded to Hold from Buy at Jefferies
- 10/21/22 UBS
- Snap price target lowered to $10 from $14 at UBS
- 10/21/22 Canaccord
- Snap price target lowered to $12 from $16 at Canaccord
- 12/15/22 Jefferies
- Trade Desk downgraded at Jefferies, Street 'overly optimistic' on digital ads
- 12/15/22 Jefferies
- Trade Desk downgraded to Hold from Buy at Jefferies
- 12/13/22 Citi
- Trade Desk initiated with a Buy at Citi
- 11/10/22 Truist
- Trade Desk price target lowered to $74 from $100 at Truist
- 12/16/22 Goldman Sachs
- Delta Air Lines resumed with a Buy at Goldman Sachs
- 12/15/22 Evercore ISI
- Delta Air Lines downgraded to In Line from Outperform at Evercore ISI
- 12/15/22 Cowen
- Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up
- 12/05/22 Jefferies
- Jefferies sees 450 point headwind to 2023 Delta CASM-ex if pilot pact passes
- 12/02/22 Barclays
- TransUnion downgraded to Equal Weight from Overweight at Barclays
- 10/26/22 Wells Fargo
- TransUnion price target lowered to $70 from $86 at Wells Fargo
- 10/26/22 Baird
- TransUnion price target lowered to $78 from $81 at Baird
- 10/24/22 Jefferies
- FHFA decision may reduce pricing power at FICO and bureaus, says Jefferies
- 12/05/22 Jefferies
- Fox Factory price target raised to $135 from $120 at Jefferies
- 12/05/22 Jefferies
- Polaris price target raised to $106 from $100 at Jefferies
- 11/30/22 Citi
- Ford price target raised to $14 from $13 at Citi
- 10/27/22 Morgan Stanley
- Ford decision to wind down Argo a positive, says Morgan Stanley
- 12/12/22 Deutsche Bank
- Micron downgraded to Hold from Buy at Deutsche Bank
- 12/07/22 Wells Fargo
- Micron price target lowered to $70 from $75 at Wells Fargo
- 12/05/22 Lynx
- Micron price target raised to $60 from $56 at Lynx
- 12/12/22 Wells Fargo
- Amazon GMV beginning to re-accelerate as softlines comps slow, says Wells Fargo
- 12/08/22 JMP Securities
- JMP views WSJ report of 'TikTok-style feed' positively for Amazon
- 12/08/22 Citi
- DoD contracts shows competitiveness of cloud industry, says Citi
- 12/06/22 Oppenheimer
- Oppenheimer remains very positive on AWS long-term despite macro weakness
- 12/15/22 Goldman Sachs
- AbCellera initiated with a Buy at Goldman Sachs
- 11/30/22 Piper Sandler
- Bebtelovimab losing EUA has 'limited impact' on Piper model for AbCellera
- 11/16/22 Truist
- AbCellera initiated with a Buy at Truist
- 11/01/22 Piper Sandler
- AbCellera price target lowered to $21 from $22 at Piper Sandler
- 12/15/22 RBC Capital
- Plug Power, Nikola partnership 'not a total surprise,' says RBC Capital
- 12/15/22 Citi
- Plug Power price target raised to $21 from $20 at Citi
- 12/13/22 UBS
- Plug Power initiated with a Buy at UBS
- 11/10/22 Truist
- Plug Power price target lowered to $18 from $32 at Truist
- 11/17/22 Credit Suisse
- AbbVie initiated with an Outperform at Credit Suisse
- 11/08/22 Societe Generale
- AbbVie downgraded at Societe Generale on blood cancer and aesthetics headwinds
- 11/08/22 Societe Generale
- AbbVie downgraded to Hold from Buy at Societe Generale
- 10/28/22 Piper Sandler
- Piper keeps Overweight rating on AbbVie despite 'rough' Q3 report
- 11/04/22 Cowen
- Nikola price target lowered to $10 from $12.50 at Cowen
- 11/04/22 Wedbush
- Nikola price target lowered to $6 from $10 at Wedbush
- 09/23/22 Northland
- Alta Equipment Group initiated with an Outperform at Northland
- 12/15/22 Morgan Stanley
- Morgan Stanley downgrades Third Harmonic after 'disappointing' discontinuation
- 12/15/22 Morgan Stanley
- Third Harmonic Bio downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/15/22 Guggenheim
- Third Harmonic 'further behind' Celldex after discontinuation, says Guggenheim
- 10/10/22 Jefferies
- Third Harmonic Bio initiated with a Buy at Jefferies
- 11/16/22 Barclays
- New Fortress Energy price target raised to $53 from $48 at Barclays
- 10/19/22 Jefferies
- New Fortress Energy initiated with a Buy at Jefferies
- 10/19/22 Barclays
- New Fortress Energy price target lowered to $48 from $54 at Barclays
- 09/09/22 BTIG
- New Fortress Energy downgraded to Neutral from Buy at BTIG
- 12/15/22 Stifel
- Roblox price target lowered to $44 from $48 at Stifel
- 12/15/22 Piper Sandler
- Piper 'little surprised' by weaker than expected Roblox metrics
- 12/15/22 Truist
- Roblox November bookings below consensus, says Truist
- 11/21/22 Citi
- Roblox price target lowered to $48 from $55 at Citi
- 11/10/22 B. Riley
- Novavax price target lowered to $74 from $83 at B. Riley
- 10/14/22 B. Riley
- Novavax price target lowered to $83 from $126 at B. Riley
- 09/22/22 JPMorgan
- Novavax downgraded to Underweight from Neutral at JPMorgan
- 08/10/22 B. Riley
- Novavax price target lowered to $126 from $171 at B. Riley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 12/13/22 UBS
- Jabil initiated with a Neutral at UBS
- 09/28/22 Raymond James
- Jabil price target lowered to $72 from $80 at Raymond James
- 09/21/22 Citi
- Citi opens 'positive 30-day catalyst watch' on Jabil into earnings
- 08/16/22 Credit Suisse
- Jabil initiated with an Outperform at Credit Suisse
- 06/16/22 Canaccord
- Hexo downgraded to Hold at Canaccord on faltering turnaround prospects
- 06/15/22 Canaccord
- Hexo downgraded to Hold from Speculative Buy at Canaccord
- 06/15/22 Alliance Global Partners
- Hexo downgraded to Neutral from Buy at Alliance Global Partners
- 06/15/22 Canaccord
- Tilray price target lowered to $7 from $9 at CanaccordHexo
- $134.11 /
-13.885 (-9.38%) - 12/06/22 UBS
- Nucor price target raised to $145 from $120 at UBS
- 10/06/22 Goldman Sachs
- Nucor price target lowered to $114 from $127 at Goldman Sachs
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 09/16/22 Credit Suisse
- Nucor price target lowered to $140 from $165 at Credit Suisse
- 10/27/22
- Western Digital sees Q2 EPS (25c)-5c, consensus 34c
- 10/27/22
- Western Digital reports Q1 EPS 20c, consensus 39c
- 08/05/22
- Western Digital sees Q1 EPS 35c-65c, consensus $1.96
- 08/05/22
- Western Digital reports Q4 EPS $1.78, consensus $1.68
- 10/21/22
- Verizon reaffirms 2022 adjusted EPS view $5.10-$5.25, consensus $5.19
- 10/21/22
- Verizon reports Q3 adjusted EPS $1.32, consensus $1.29
- 10/20/22
- Notable companies reporting before tomorrow's open
- 11/09/22
- Trade Desk sees Q4 revenue 'at least' $490M, consensus $509.12M
- 11/09/22
- Trade Desk reports Q3 adjusted EPS 26c, consensus 22c
- 11/08/22
- Notable companies reporting before tomorrow's open
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 07/20/22
- Tesla reports Q2 EPS $2.27, consensus $1.85
- 07/20/22
- Notable companies reporting after market close
- 10/25/22
- TransUnion sees FY22 adjusted EPS $3.63-$3.69, consensus $3.73
- 10/25/22
- TransUnion sees Q4 adjusted EPS 80c-86c, consensus 81c
- 10/25/22
- TransUnion sees FY22 organic revenue growth approximately 7%
- 10/25/22
- TransUnion reports Q3 adjusted EPS 93c, consensus 91c
- 10/20/22
- AT&T raises FY22 adjusted cont ops EPS view to '$2.50 or higher'
- 10/20/22
- AT&T reports Q3 adjusted EPS 68c, consensus 61c
- 10/19/22
- Notable companies reporting before tomorrow's open
- 10/20/22
- Snap reports Q3 adjusted EPS 8c, consensus (1c)
- 10/20/22
- Notable companies reporting after market close
- 08/31/22
- Snap says forward looking revenue visibility 'remains limited'
- 08/31/22
- Snap sees Q3 revenue growth at 8% through August 29
- 11/09/22
- Roblox reports Q3 EPS (50c), consensus (33c)
- 08/09/22
- Roblox reports Q2 EPS (30c), consensus (23c)
- 11/08/22
- Plug Power reaffirms FY23 revenue view $1.4B, consensus $1.37B
- 11/08/22
- Plug Power reaffirms FY22 revenue view 5%-10% lower than $900M-$925M guidance
- 11/08/22
- Plug Power reports Q3 EPS (30c), consensus (23c)
- 11/08/22
- Notable companies reporting after market close
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/16/22
- Nvidia sees Q4 revenue $6B, +/- 2%, consensus $6.09B
- 11/16/22
- Nvidia reports Q3 EPS 58c, consensus 69c
- 11/16/22
- Notable companies reporting after market close
- 08/24/22
- Nvidia down 5% after Q2 report, Q3 guidance
- 12/14/22
- Novavax reaffirms FY22 revenue guidance approximately $2B, consensus $2.1B
- 11/08/22
- Novavax sees FY22 revenue $2B, consensus $2.04B
- 11/08/22
- Novavax reports Q3 EPS ($2.15) vs. ($4.31) last year
- 08/08/22
- Novavax cuts FY22 revenue view to $2B-$2.3B from $4B-$5B, consensus $4.27B
- $134.11 /
-13.885 (-9.38%) - 12/15/22
- Nucor says FY22 EPS 'remains on track to exceed $23.16 set in 2021'
- 12/15/22
- Nucor sees Q4 EPS $4.25-$4.35, consensus $4.41
- 10/20/22
- Nucor sees Q4 earnings 'decreased' from Q3, consensus $5.08
- 10/20/22
- Nucor reports Q3 EPS $6.50, consensus $6.73
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 11/02/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Nikola sees Q3 revenue $21.13M-$24.38M, consensus $38.65M
- $290.35 /
-27.83 (-8.75%) - 10/18/22
- Netflix sees Q4 EPS 36c, consensus $1.12
- 10/18/22
- Netflix reports Q3 EPS $3.10, consensus $2.13
- 10/18/22
- Notable companies reporting after market close
- 07/19/22
- Netflix sees Q3 EPS $2.14, consensus $2.77
- 11/08/22
- New Fortress Energy reports Q3 EPS 41c, consensus 80c
- 08/04/22
- New Fortress Energy reports Q2 adjusted EPS 69c, consensus 50c
- 09/29/22
- Micron sees Q2 revenue range similar to Q1
- 09/29/22
- Micron sees Q1 adjusted EPS 4c, plus or minus 10c, consensus 64
- 09/29/22
- Micron reports Q4 adjusted EPS $1.45, consensus $1.30
- 09/29/22
- Notable companies reporting after market close
- 12/15/22
- Lennar sees Q1 EPS $1.40-$1.70, consensus $2.40
- 12/14/22
- Lennar reports Q4 adjusted EPS $5.02, consensus $4.89
- 12/14/22
- Notable companies reporting after market close
- 09/22/22
- Lennar sees Q4 EPS $4.65-$5.30, consensus $5.40
- 12/15/22
- Jabil raises FY23 core EPS view to $8.40 from $8.15, consensus $8.18
- 12/15/22
- Jabil sees Q2 core EPS $1.64-$2.04, consensus $1.81
- 12/15/22
- Jabil reports Q1 core EPS $2.31, consensus $2.24
- 09/27/22
- Jabil sees Q1 core EPS $2.00-$2.40, consensus $2.10
- 12/15/22
- HEXO reports Q1 net revenue C$35.8M vs. C$50.2M last year
- 11/01/22
- Hexo reports Q4 revenue $42.49M, consensus $31.77M
- 11/03/22
- FIS sees FY22 EPS $6.60-$6.66, consensus $7.02
- 11/03/22
- FIS sees Q4 EPS 1.66-$1.72 , consensus $2.07
- 11/03/22
- FIS sees Q4 EPS 1.66-$1.72 , consensus $2.07
- 11/03/22
- FIS reports Q3 EPS $1.74, consensus $1.75
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 10/26/22
- Notable companies reporting after market close
- 07/27/22
- Ford reports Q2 adjusted EPS 68c, consensus 45c
- 07/27/22
- Notable companies reporting after market close
- 12/14/22
- Delta Air Lines raises Q4 adjusted EPS view to $1.35-$1.40 from $1.00-$1.25
- 12/14/22
- Delta Air Lines sees FY23 adjusted EPS $5.00-$6.00, consensus $4.80
- 12/14/22
- Delta Air Lines sees FY22 revenue view $45.5B-$45.6B, consensus $45.54B
- 12/14/22
- Delta Air Lines sees FY22 adjusted EPS $3.07-$3.12, consensus $2.89
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 10/27/22
- Notable companies reporting after market close
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 11/08/22
- AbCellera reports Q3 EPS 9c, consensus 4c
- 08/09/22
- AbCellera reports Q2 EPS (2c), consensus (2c)
- 11/08/22
- Caribou Biosciences reports Q3 revenue $3.3M, consensus $3.7M
- 10/28/22
- AbbVie sees FY22 revenue approximately $58.2B, consensus $59.92B
- 10/28/22
- AbbVie sees Q4 adjusted EPS $3.65-$3.69, consensus $3.75
- 10/28/22
- AbbVie narrows FY22 adjusted EPS view to $13.84-$13.88 from $13.76-$13.96
|